Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Western

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Sex-specific genetic regulation of proteomics in cerebrospinal fluid uncovers genetic causes for sex differences in neurodegenerationSoomin Song, Anh N Do, Lihua Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 5, 2026
APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's DiseaseFuhai Li, Yike Chen, Daniel Western, et al.
Research Square|June 17, 2024
Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracell signaling pathwaysCarlos Cruchaga, Joseph Bradley, Daniel Western, et al.
Research Square|February 27, 2024
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's diseaseCarlos Cruchaga, Muhammad Ali, Yuanyuan Shen, et al.
Science Translational Medicine|June 26, 2024
Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with <i>APOE</i> ε4 and atomoxetine treatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Proteomic Network Analysis of Alzheimer's Disease Cerebrospinal Fluid Reveals Alterations Associated with <i>APOE</i> ε4 Genotype and Atomoxetine TreatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Science Translational Medicine|April 29, 2026
Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological diseaseDaniel Western, Chengran Yang, Jigyasha Timsina, et al.
Nature Genetics|November 11, 2024
Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traitsCiyang Wang, Chengran Yang, Daniel Western, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Sex-specific genetic regulation of proteomics in cerebrospinal fluid uncovers genetic causes for sex differences in neurodegenerationSoomin Song, Anh N Do, Lihua Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 5, 2026
APOE-stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's DiseaseFuhai Li, Yike Chen, Daniel Western, et al.
Research Square|June 17, 2024
Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracell signaling pathwaysCarlos Cruchaga, Joseph Bradley, Daniel Western, et al.
Research Square|February 27, 2024
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's diseaseCarlos Cruchaga, Muhammad Ali, Yuanyuan Shen, et al.
Science Translational Medicine|June 26, 2024
Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with <i>APOE</i> ε4 and atomoxetine treatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Proteomic Network Analysis of Alzheimer's Disease Cerebrospinal Fluid Reveals Alterations Associated with <i>APOE</i> ε4 Genotype and Atomoxetine TreatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Science Translational Medicine|April 29, 2026
Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological diseaseDaniel Western, Chengran Yang, Jigyasha Timsina, et al.
Nature Genetics|November 11, 2024
Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traitsCiyang Wang, Chengran Yang, Daniel Western, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma ClassificationYing Xu, Daniel Western, Gyujin Heo, et al.
Pageof 6